Acta Vet. Brno 2023, 92: 289-301
https://doi.org/10.2754/avb202392030289
Assessment of plasma protein C activity in dogs with portosystemic shunt
References
1. T, Ishikawa C, Ishigaki K, Horikirizono H, Iizuka K, Nagumo T, Tamura K, Seki M, Edamura K, Asano K 2019: Computed tomographic-derived measurements of shunt fraction and hepatic perfusion in dogs with a single extrahepatic portosystemic shunt in a clinical setting. J Am Vet Med Assoc 255: 821-827
<https://doi.org/10.2460/javma.255.7.821>
2. LR, Gacad RC, Kaminsky-Russ K, Gregory CR, Mullen KD 1997: Endogenous benzodiazepine activity in the peripheral and portal blood of dogs with congenital portosystemic shunts. Vet Surg 26: 189-194
<https://doi.org/10.1111/j.1532-950X.1997.tb01483.x>
3. AC, Weisse C 2007: Portosystemic shunts and portal venous hypoplasia. Stand Care Emerg Crit Care Med 9: 1-11
4. AC, Tobias KM 2009: Portosystemic vascular anomalies. Vet Clin North Am Small Anim Pract 39: 513-541
<https://doi.org/10.1016/j.cvsm.2009.02.004>
5. Berent AC, Tobias KM 2018: Hepatic Vascular Anomalies. In: Johnston SA and Tobias KM: Veterinary Surgery: Small Animal. Second edn. St. Louis, Elsevier, 2,600 p.
6. MF, Kyles AE, Griffey SM, Gregory CR 2004: Evaluation of the characteristics of venous occlusion after placement of an ameroid constrictor in dogs. Vet Surg 33: 597-605
<https://doi.org/10.1111/j.1532-950x.2004.04082.x>
7. P, Tivers M, Packer R, Brockman D, Ortiz V, Newson K, Lipscomb V 2017: Long-term serum bile acid concentrations in 51 dogs after complete extrahepatic congenital portosystemic shunt ligation. J Small Anim Pract 58: 454-460
<https://doi.org/10.1111/jsap.12685>
8. Cullen JM, van den Ingh TSGAM, Bunch SE, Rothuizen J, Washabau RJ, Desmet VJ 2006: Morphological classification of circulatory disorders of the canine and feline liver. In: WSAVA Liver Standardization Group: Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases. St. Louis, Elsevier, 130 p.
9. AM, Freeman LM, Shaw SP, Brooks MB, Rozanski EA, Rush JE 2003: Hemostatic changes in dogs with naturally occurring sepsis. J Vet Intern Med 17: 674-679
<https://doi.org/10.1111/j.1939-1676.2003.tb02499.x>
10. AM, Rozanski EA, Freeman LM, Li W 2008: Serial evaluation of protein C and antithrombin in dogs with severe sepsis. J Vet Intern Med 22: 26-30
<https://doi.org/10.1111/j.1939-1676.2007.0021.x>
11. N, Serrano G, Croubels S, Stock E, Vandermeulen E, Paepe D, von Luckner J, de Rooster H 2021c: Evaluation of serum lidocaine/monoethylglycylxylidide concentration to assess shunt closure in dogs with extrahepatic portosystemic shunts. J Vet Intern Med 35: 261-268
<https://doi.org/10.1111/jvim.16030>
12. N, Serrano G, Paepe D, de Rooster H 2020: Liver function tests in dogs with congenital portosystemic shunts and their potential to determine persistent shunting after surgical attenuation. Vet J 261: 105478
<https://doi.org/10.1016/j.tvjl.2020.105478>
13. N, Serrano G, Meyer E, Demeyere K, Paepe D, Vandermeulen E, Stock E, de Rooster H 2021a: Serum hyaluronic acid, a marker for improved liver perfusion after gradual surgical attenuation of extrahepatic portosystemic shunt closure in dogs. Vet J 268: 105604
<https://doi.org/10.1016/j.tvjl.2020.105604>
14. N, Paepe D, Serrano G, Vandenabeele S, Stock E, Van Acker L, de Rooster H 2021b: Plasma amino acid profiles in dogs with closed extrahepatic portosystemic shunts are only partially improved 3 months after successful gradual attenuation. J Vet Intern Med 35: 1347-1354
<https://doi.org/10.1111/jvim.16135>
15. AM, Abramov PN, Abdelhamid FM 2020: Clinical characteristics, serum biochemical changes, and expression profile of serum cfa-miRNAs in dogs confirmed to have congenital portosystemic shunts accompanied by liver pathologies. Vet Sci 7: 35
<https://doi.org/10.3390/vetsci7020035>
16. CJ Jr, Yan SB 2000: Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit Care Med 28: 49-56
<https://doi.org/10.1097/00003246-200009001-00011>
17. MJ, van den Ingh TS, Rothuizen J 2006: Diagnostic value of fasting plasma ammonia and bile acid concentrations in the identification of portosystemic shunting in dogs. J Vet Intern Med 20: 13-19
<https://doi.org/10.1111/j.1939-1676.2006.tb02818.x>
18. GB, Culp WT, Mayhew KN, Mayhew P, Steffey MA, Zwingenberger A 2014: Evaluation of in vivo behavior of ameroid ring constrictors in dogs with congenital extrahepatic portosystemic shunts using computed tomography. Vet Surg 43: 834-842
<https://doi.org/10.1111/j.1532-950X.2014.12196.x>
19. D, Lester C, de Laforcade A, Webster CR 2013: Thromboelastographic evaluation of dogs with congenital portosystemic shunts. J Vet Intern Med 27: 1262-1267
<https://doi.org/10.1111/jvim.12130>
20. MB, Nelson LL, Hauptman JG, Nelson NC 2014: Analysis of the relationship of extrahepatic portosystemic shunt morphology with clinical variables in dogs: 53 cases (2009-2012). J Am Vet Med Assoc 245: 540-549
<https://doi.org/10.2460/javma.245.5.540>
21. CL, Superina RA, Whitington PF 2003: Surgical restoration of portal flow corrects procoagulant and anticoagulant deficiencies associated with extrahepatic portal vein thrombosis. J Pediatr 142: 197-199
<https://doi.org/10.1067/mpd.2003.93>
22. RM, Ward M, Marlar RA 1989: Protein C activity levels in endotoxin-induced disseminated intravascular coagulation in a dog model. Thromb Res 55: 297-307
<https://doi.org/10.1016/0049-3848(89)90062-5>
23. ML, Kyles AE, Hardie EM, Kass PH, Adin CA, Flynn AK, De Cock HE, Gregory CR 2005: Evaluation of ameroid ring constrictors for treatment for single extrahepatic portosystemic shunts in dogs: 168 cases (1995-2001). J Am Vet Med Assoc 226: 2020-2030
<https://doi.org/10.2460/javma.2005.226.2020>
24. A, Lorenzová J, Stehlík L, Proks P, Filipejová Z, Nečas A 2020: Clinical and laboratory outcome after surgical treatment of single congenital extrahepatic portosystemic shunt using ameroid constrictor in 25 dogs. Acta Vet Brno 89: 357-365
<https://doi.org/10.2754/avb202089040357>
25. A, Urbanová L, Staňková L, Pompová A, Filipejová Z, Somerlíková K, Řeháková K, Nečas A 2022: Protein C activity in dogs with gastric dilatation and volvulus. Acta Vet Brno 91: 35-42
<https://doi.org/10.2754/avb202291010035>
26. M, Kitshoff A, Devriendt N, De Ridder M, Quist-Rybachuk G, de Rooster H 2016: Transdiaphragmatic approach to attenuate porto-azygos shunts inserting in the thorax. Vet Surg 45: 1013-1018
<https://doi.org/10.1111/vsu.12557>
27. K, Fischer A, Hartmann K 2010: Sensitivity and specificity of fasting ammonia and serum bile acids in the diagnosis of portosystemic shunts in dogs and cats. Vet Clin Pathol 39: 57-64
<https://doi.org/10.1111/j.1939-165X.2009.00178.x>
28. DP, Rubin S 1993: Serum bile acids and the assessment of hepatic function in dogs and cats. Can Vet J 34: 215-220
29. G, Charalambous M, Devriendt N, de Rooster H, Mortier F, Paepe D 2019: Treatment of congenital extrahepatic portosystemic shunts in dogs: A systematic review and meta-analysis. J Vet Intern Med 33: 1865-1879
<https://doi.org/10.1111/jvim.15607>
30. G, Devriendt N, Paepe D, de Rooster H 2021: Serum insulin-like growth factor-1 as a marker of improved liver function and surgical outcome in dogs with congenital extrahepatic portosystemic shunts. Vet J 274: 105716
<https://doi.org/10.1016/j.tvjl.2021.105716>
31. C, Weisse C, Berent A, Tozier E 2022: Protein C and comparative biochemical changes in dogs treated with percutaneous transvenous coil embolization of congenital intrahepatic portosystemic shunts. Vet Surg 51: 125-135
<https://doi.org/10.1111/vsu.13719>
32. V, Rothuizen J, Voorhout G 2004a: Standard planes for ultrasonographic examination of the portal system in dogs. J Am Vet Med Assoc 224: 713-716
<https://doi.org/10.2460/javma.2004.224.713>
33. V, van Sluijs FJ, Rothuizen J, Voorhout G 2004b: Ultrasonographic assessment of hemodynamic changes in the portal vein during surgical attenuation of congenital extrahepatic portosystemic shunts in dogs. J Am Vet Med Assoc 224: 395-402
<https://doi.org/10.2460/javma.2004.224.395>
34. MS, Handel I, Gow AG, Lipscomb VJ, Jalan R, Mellanby RJ 2014: Hyperammonemia and systemic inflammatory response syndrome predicts presence of hepatic encephalopathy in dogs with congenital portosystemic shunts. PLoS One 9: e82303
<https://doi.org/10.1371/journal.pone.0082303>
35. O, Center SA, Brooks MB, Erb HN, Warner KL, Deal W 2006: Evaluation of plasma protein C activity for detection of hepatobiliary disease and portosystemic shunting in dogs. J Am Vet Med Assoc 229: 1761-1771
<https://doi.org/10.2460/javma.229.11.1761>
36. M, Lussier B, Huneault L, Gatineau M 2018: Comparative outcomes between ameroid ring constrictor and cellophane banding for treatment of single congenital extrahepatic portosystemic shunts in 49 dogs (1998-2012). Vet Surg 47: 179-187
<https://doi.org/10.1111/vsu.12747>
37. N, Pil S, Devriendt N, Or M, Vandermeulen E, Serrano G, Paepe D, Bosmans T, de Rooster H 2020: Diagnostic value of blood variables following attenuation of congenital extrahepatic portosystemic shunt in dogs. Vet Rec 187: e48
<https://doi.org/10.1136/vr.105296>
38. L, van Steenbeek FG, Favier RP, Kummeling A, Leegwater PA, Rothuizen J 2012: Distribution of extrahepatic congenital portosystemic shunt morphology in predisposed dog breeds. BMC Vet Res 8: 112
<https://doi.org/10.1186/1746-6148-8-112>
39. G, Spee B, Rothuizen J, van Straten M, Favier RP 2015: Diagnostic value of the rectal ammonia tolerance test, fasting plasma ammonia and fasting plasma bile acids for canine portosystemic shunting. Vet J 204: 282-286
<https://doi.org/10.1016/j.tvjl.2015.04.020>
40. J, Moritz A, Kramer M, Bauer N 2015: Hemostatic variables, plasma lactate concentration, and inflammatory biomarkers in dogs with gastric dilatation-volvulus. Tierärztl Prax Ausg K Kleintiere Heimtiere 43: 389-398
41. JC, Krahwinkel DJ Jr, Bright RM, Daniel GB, Toal RL, Rohrbach B 1996: Gradual occlusion of extrahepatic portosystemic shunts in dogs and cats using the ameroid constrictor. Vet Surg 25: 495-502
<https://doi.org/10.1111/j.1532-950X.1996.tb01449.x>
42. SB, Dhainaut JF 2001: Activated protein C versus protein C in severe sepsis. Crit Care Med 29: 69-74
<https://doi.org/10.1097/00003246-200107001-00024>
